Browsing by Author Lechner-Scott, Jeannette

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2016Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched studyBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Kister, Ilya; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Slee, Mark; Spelman, Timothy; Central Clinical School: Inst. of Clinical NeurosciencesDiscontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched study, Journal of Neurology, Neurosurgery and Psychiatry, vol.87, 10, 2016,pp 1133-1137
2016Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched studyBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Kister, Ilya; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Slee, Mark; Spelman, Timothy; Central Clinical School: Inst. of Clinical NeurosciencesDiscontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched study, Journal of Neurology, Neurosurgery and Psychiatry, vol.87, 10, 2016,pp 1133-1137
2010IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility lociBooth, David; Heard, Robert; Stewart, Graeme; Cepok, Sabine; Cox, Mathew; Dobosi, R; Esposito, F; et al, various; Goris, A.; Kockum, J; Lechner-Scott, Jeannette; Leppa, V; Patsopolous, N A; Scott, Rodney J.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteIL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci, Genes and Immunity, vol.11, 5,pp 397-405
2010MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole BloodBooth, David; Gandhi, Kaushal; Stewart, Graeme; ANZgene Multiple Sclerosis Genetics Consortium, et al; Broadley, Simon; Cairns, Murray J; Carroll, Adam; Cox, Mathew; Lechner-Scott, Jeannette; Moscovis, Sophia; Scott, Rodney J.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteMicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood, PLoS One, vol.5, 8,pp e12132 - 1-e12132 - 7
2015A new era in the treatment of multiple sclerosisBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, S; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Medicine; Central Clinical School: MedicineA new era in the treatment of multiple sclerosis, Medical Journal of Australia, vol.203, 3, 2015,pp 139-141
2014Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by seasonBooth, David; Gatt, Prudence; Liddle, Christopher; McKay, Fiona Catherine; Parnell, Grant; Schibeci, Stephen; Stewart, Graeme; Vucic, Steve; Broadley, Simon; Krupa, Malgorzata; Lechner-Scott, Jeannette; Montgomery, Grant; Powell, Jospeh; Slee, Mark; Visscher, Peter; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: Medicine; Medicine; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season, Multiple Sclerosis Journal, vol.20, 6, 2014,pp 675-685
2015Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosisBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Girard, Marc; Grammond, P; Horakova, Dana; Izquierdo, Guillermo; Jokubaitis, Vilija; Kalincik, Tomas; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Pucci, Eugenio; Rozsa, Csilla; Spelman, Timothy; Trojano, Maria; Central Clinical School: Inst. of Clinical NeurosciencesSwitch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis, Annals of Neurology, vol.77, 3, 2015,pp 425-435
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapiesBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1835-1846
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacyBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1847-1856
2014Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendationsBarnett, Michael; Heard, Robert; Parratt, John Douglas; Pollard, John; Reddel, Stephen; Spies, Judith; Boggild, Mike; Brew, B.J. (Bruce); Broadley, Simon; Butzkueven, Helmut; et al, Various; Hodgkinson, Suzanne J.; Kermode, Allan; Lechner-Scott, Jeannette; Macdonell, Richard A.L.; Marriott, Mark; Mason, Deborah F.; Shaw, Cameron P.; Slee, Mark; Taylor, Bruce V.; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineTherapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations, Journal of Clinical Neuroscience, vol.21, 11, 2014,pp 1857-1865
2010A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple SclerosisBooth, David; Gandhi, Kaushal; Heard, Robert; McKay, Fiona Catherine; Stewart, Graeme; Vucic, Steve; Berretta, Regina; Broadley, Simon; Cox, Matthew B; Inostroza-Ponta, Mario; Lechner-Scott, Jeannette; Mellor, Drew; Moscato, Pablo; Riveros, Carlos; Scott, Rodney; Vaezpour, S Yahya; Williams, David W; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis, PLoS One, vol.5, 12, 2010,pp e14176-1-e14176-28